Sort
78,016 grants matching “breast cancer”
Asparagine Synthetase as a Biomarker for L-asparaginase Rx of Ovarian Cancer
$580,865John N Weinstein · Basic Sciences · Z01 · FY2007 · CA
A phase II multi-center trial evaluating dual targeting of the PI3K/AKT and NOS pathways for treating metaplastic breast cancer (MpBC)
$580,861Jenny C-N Chang · Methodist Hospital Research Institute · U01 · FY2024 · CA
Optimizing functional recovery of breast cancer survivors
$580,853Kathleen Doyle Lyons · Dartmouth-Hitchcock Clinic · R01 · FY2021 · CA
CEDAR RAPIDS ONCOLOGY PROJECT
$580,846Cedar Rapids Oncology Project · U10 · FY2002 · CA
A Randomized Controlled Trial: Genetic Counseling Patient Preference Intervention via Electronic Health Record Portal vs. Conventional Genetic Counseling for Women at Elevated Risk for Breast Cancer
$580,791Kevin M. Sweet · Ohio State University · R01 · FY2022 · CA
Novel RORgamma antagonists for inflammation and autoimmune disease
$580,731F Javier Piedrafita · Torrey Pines Inst For Molecular Studies · R01 · FY2015 · AI
Use of silver nanostructures on microtransponders in ultra-sensitive assay
$580,711Wlodek Mandecki · Pharmaseq, Inc. · R44 · FY2011 · CA
HSCT-CHESS to Enhance Hematopoietic Transplant Recovery
$580,674Susan Kenyon Parsons · Tufts Medical Center · R01 · FY2008 · CA
Shared Genomic Segment Analysis and Tumor Subtyping in High-Risk BrCa Pedigrees
$580,674Nicola J Camp · University Of Utah · R01 · FY2015 · CA
Integrated 3D Xray and Dynamic Tomographic Optical Breast Imaging System
$580,668David A Boas · Massachusetts General Hospital · R01 · FY2012 · CA
Comprehensive Analysis of Estrogen Receptor Genomic Action
$580,656Myles A Brown · Dana-Farber Cancer Inst · R01 · FY2010 · DK
Characterization & Prevention of Chemotherapy-Induced Damage to Ovarian Reserve
$580,619Kutluk H Oktay · New York Medical College · R01 · FY2015 · HD
The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and
$580,614Richard R Barakat · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Estimating and Mitigating Thyroid Cancer Overdiagnosis: A Mathematical Modeling Approach
$580,599David O. Francis · University Of Wisconsin-Madison · R01 · FY2020 · CA
Centralization of Cancer Care: Implications for Access, Outcomes, and Disparities
$580,586Bruce L. Jacobs · University Of Pittsburgh At Pittsburgh · R37 · FY2024 · CA
Automated Density Measures for Estimating Breast Cancer Risk and Therapy Response
$580,457Celine M Vachon · Mayo Clinic Rochester · R01 · FY2014 · CA
Choreography of Eukaryotic DNA Replication
$580,453Bonita J Brewer · University Of Washington · R35 · FY2018 · GM
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.
$580,448George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2015 · CA
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.
$580,448George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2014 · CA
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.
$580,448George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2017 · CA
Human-Enzyme Mediated, Systemic Depletion of Cystine for Cancer Treatment.
$580,448George Georgiou Georgiou · University Of Texas At Austin · R01 · FY2016 · CA
SOY AND ESTROGEN INTERACTIONS IN THE BREAST
$580,432J. Mark Cline · Wake Forest University Health Sciences · R01 · FY2007 · AT
The Role of 27-hydroxycholesterol in Breast Cancer: A Population-Based Multiethnic Study
$580,411Lenora Wm Loo · University Of Hawaii At Manoa · R01 · FY2022 · CA
An integrated theranostic system for breast cancer
$580,371Elisa E Konofagou · Columbia University Health Sciences · R01 · FY2019 · CA
Medications, Genetic Variability &Breast Cancer
$580,352University Of Wisconsin Madison · R01 · FY2005 · CA